The Business of Cannabis

First U.S. Marijuana Stock Now Trading On NYSE

Last week, Trulieve Cannabis became the first U.S. cannabis operator to list on the New York Stock Exchange. The stock is now trading under the symbol "TRLV." Although a publicly traded company moving up to the NYSE is not uncommon, it is in the cannabis...

New CANNRA President: Hanna, U.S. Army Vet From Michigan

For the first time ever, a United States military veteran — from Michigan —  has been elected president of the Cannabis Regulators Association (CANNRA), an international non-profit organization founded in 2020. Michigan Cannabis Regulatory Agency...

Maryland Collects $26.2 Million In Cannabis Tax Revenue In First Quarter

The Maryland Office of the Comptroller has reported that the state collected $26.2 million in cannabis sales tax revenue between January and March 2026. Maryland law imposes a 12% sales and use tax on retail sales of adult-use cannabis and cannabis products....

After Losing Its License, Minnesota’s First Cannabis Testing Lab Exits Pot Industry

One of Minnesota's longstanding cannabis testing labs has ended its cannabis and hemp testing program following regulatory troubles. Legend Technical Services announced this week it has shut down its cannabis testing program. This comes weeks after the...

RAIR Provisioning Center Coming To Big Rapids

A new marijuana provisioning center, RAIR, is estimated to begin construction this September in front of Dunham's Sports, at 702 Perry Avenue. “We were anxious to get into the cannabis industry, like many businesses,” RAIR Chief Operating Officer Patrick Frakes said....

FDA Reports on Purity of Commercially Available CBD Products

Fewer than half of the commercially available hemp/CBD products tested this year by the US Food and Drug Administration (FDA) contain percentages of cannabidiol that are consistent with the products’ labelling, according to data provided by the agency in a recently...

FDA Releases Initial Guidelines for Cannabis-Derived Drugs

The Food and Drug Administration released a draft of rules that companies should follow to develop cannabis-derived drugs -- a new category that has exploded with few federal laws to govern it. The guidelines cover drugs and treatments containing cannabis...